Parkinson’s Disease in 4 Minutes | High-Yield for USMLE | PLAB скачать в хорошем качестве

Parkinson’s Disease in 4 Minutes | High-Yield for USMLE | PLAB

Struggling to understand Parkinson’s disease? In this 4-minute high-yield whiteboard animation, we’ll simplify everything — from dopamine loss to the TRAP symptoms — so you never forget it again. Perfect for USMLE, PLAB, NEET-PG preparation, this short video breaks down the pathophysiology, clinical features, and treatment of Parkinson’s disease using clear visuals and easy logic. Parkinson’s Disease is one of the most tested neurological disorders in exams — yet many students get confused by the basal ganglia pathways and dopamine imbalance. This concise, high-yield explainer covers: ✅ The role of dopamine in the nigrostriatal pathway ✅ Direct vs Indirect pathway mechanism ✅ TRAP symptoms (Tremor, Rigidity, Akinesia, Postural Instability) ✅ Pharmacologic logic behind Levodopa, Dopamine Agonists, MAO-B, and COMT inhibitors ✅ Key differentials and high-yield exam clues Whether you’re studying for USMLE Step 1, PLAB, NEET-PG or just revising neurology concepts — this 4-minute breakdown will save you hours of reading. 🧠 Remember: “TRAP the dopamine loss” — that’s Parkinson’s in one line. 🎓 Subscribe to The Why Medic for more simplified medical explainers that make complex topics finally make sense. _________________________________________________________________________________________ Timestamps: 0:00 - 0:10 - Clinical Question 0:11 - 0:38 - Introduction to Parkinson's Disease 0:39 - 1:15 - Pathophysiology 1:23 - 1:55 - Clinical Features 2:00 - 2:19 - Non motor symptoms 2:20 - 2:35 - Diagnosis 2:36 - 3:30 - Treatment 3:31 - 3:55 - Answer reveal _________________________________________________________________________________________ #ParkinsonsDisease #USMLE #PLAB #NEETPG #MedicalStudents #HighYieldMedicine #TheWhyMedic #NeurologySimplified Attributions: "Lewy bodies (alpha synuclein inclusions)" by Suraj Rajan, via Wikimedia Commons, licensed under Attribution-Share Alike 3.0 Unported.